Treatment of small cell lung cancer

Critical Reviews in Oncology/Hematology

Volumn 52, Issue 2, 2004, Pages 117-126

  Kurup, Anupama ^a   Hanna, Nasser H ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Carboplatin; Chemoradiation; Cisplatin; Etoposide; Prophylactic cranial irradiation; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BEC 2 VACCINE; CANCER VACCINE; CARBOPLATIN; CARMUSTINE; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GEMCITABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; IFOSFAMIDE; IRINOTECAN; LOMUSTINE; MARIMASTAT; MESNA; METHOTREXATE; NAVELBINE; PACLITAXEL; PEMETREXED; PROTEIN BCL 2; TENIPOSIDE; TOPOTECAN; UNCLASSIFIED DRUG; VINCRISTINE; VINDESINE;

ACUTE TOXICITY; ANEMIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BRAIN METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOSENSITIVITY; CLINICAL TRIAL; COGNITIVE DEFECT; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; ESOPHAGITIS; ESOPHAGUS DISEASE; FEBRILE NEUTROPENIA; HUMAN; INCIDENCE; INFECTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PROGNOSIS; RADIATION DOSE; RADIOSENSITIVITY; REVIEW; SIDE EFFECT; SMOKING; THORAX TUMOR; THROMBOCYTOPENIA; TOXICITY; UNITED STATES; WEIGHT REDUCTION;

BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; HUMANS; PROGNOSIS;

EID: 6944224365     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2004.08.005     Document Type: Review

References (96)

1. R.T. Greenlee, M. Hill-Harmon, and T. Murray Cancer Statistics 2001 CA Cancer J Clin 51 2001 16
2. N.C. Page, W.L. Read, and R.M. Tierney The epidemiology of small cell lung cancer [abstract] Proc Am Soc Clin Oncol 21 2002 305a
3. R. Green, E. Humphrey, H. Close, and M. Patno Alkylating agents in bronchogenic carcinoma Am J Med 46 1969 516 525
4. C. Mountain Clinical biology of small cell carcinoma: relationship to surgical therapy Semin Oncol 5 1978 272 279
5. R.N. Proctor Tobacco and the global lung cancer epidemic Nature Rev Cancer 1 2001 82 86
6. J.H. Schiller Small cell lung cancer: defining a role for emerging platinum drugs Oncology 63 2002 105 114
7. N.H. Hanna, and L.H. Einhorn Small-cell lung cancer: state of the art Clin Lung Cancer 4 2 2002 87 94
8. M. Zelen Keynote address on biostatistics and data retrieval Cancer Chemother Rep 4 2 1973 31 42
9. J. Murren, E. Glatstein, and H.I. Pass Small cell lung cancer V.T. DeVita S. Hellman S.A. Rosenberg Cancer: principles and practice of oncology 2001 Lippincott, Williams and Wilkins Philadelphia 983 1018
10. N. Miyazawa, R. Tsuchiya, and T. Naruke A clinicopathological study of surgical treatment for small cell carcinoma Jpn J Clin Oncol 16 1986 297 307
11. U. Lassen, and H.H. Hansen Surgery in limited stage small cell lung cancer Cancer Treatment Rev 25 2 1999 67 72
12. D.H. Johnson, L.H. Einhorn, I. Mandelbaum, S.D. Williams, and F.A. Greco Postchemotherapy resection of residual tumor in limited stage small cell lung cancer Chest 92 2 1987 241 246
13. T. Lad, S. Piantadosi, and P. Thomas A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy Chest 106 1994 320S 323S
14. M.C. Perry, W.L. Eaton, and K.J. Propert Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung N Engl J Med 316 15 1987 912 918
15. D.H. Johnson, D. Bass, and L.H. Einhorn Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group J Clin Oncol 11 7 1993 1223 1229
16. P. Warde, and D. Payne Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis J Clin Oncol 10 6 1992 890 895
17. J.P. Pignon, R. Arriagada, and D.C. Ihde A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 23 1992 1618 1624
18. L.H. Einhorn, J. Crawford, R. Birch, G. Omura, D.H. Johnson, and F.A. Greco Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer J Clin Oncol 6 3 1988 451 456
19. A.T. Turrisi, K. Kim, and R. Blum Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 4 1999 265 271
20. K. Osterlind, H.H. Hansen, H.S. Hansen, P. Dombernowsky, M. Hansen, and M. Rorth Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up Br J Cancer 54 1 1986 7 17
21. S. Sundstrom, R.M. Bremnes, and S. Kaasa Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up J Clin Oncol 20 24 2002 4665 4672
22. A. Gregor, P. Drings, and J. Burghouts Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study J Clin Oncol 15 8 1997 2840 2849
23. M. Takada, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104 J Clin Oncol 20 14 2002 3054 3060
24. E. Work, O.S. Nielson, S.M. Bentzen, K. Fode, and T. Palshof Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group J Clin Oncol 15 9 1997 3030 3037
25. N. Murray, P. Coy, and J.L. Pater Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 11 2 1993 336 344
26. B. Jeremic, Y. Shibamoto, L. Acimovic, and S. Milisavljevic Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study J Clin Oncol 15 3 1997 893 900
27. J.A. Bonner, J.A. Sloan, and T.G. Shanahan Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma J Clin Oncol 17 9 1999 2681 2691
28. R. Arriagada, T. LeChevalier, and F. Borie Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission J Natl Cancer Inst 87 3 1995 183 190
29. E.G. Shaw, J.Q. Su, R.T. Eagen, J.R. Jett, A.W. Maksymiuk, and F.A. Deigert Prophylactic carnial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group databases J Clin Oncol 12 11 1994 2327 2332
30. A. Gregor, A. Cull, and R.J. Stephens Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomized trial Eur J Cancer 33 11 1997 1752 1758
31. A. Auperin, R. Arriagada, and J.P. Pignon Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission N Engl J Med 341 7 1999 476 484
32. D.V. Jackson Jr., F. Richard II, and M.R. Cooper Prophylactic cranial irradiation in small cell carcinoma of the lung. A randomized study JAMA 237 25 1977 2730 2733
33. L.H. Einhorn, W.H. Bond, N. Hornback, and B.T. Joe Long-term results in combined-modality treatment of small cell carcinoma of the lung Semin Oncol 5 3 1978 309 313
34. J.F. Fleck, L.H. Einhorn, R.C. Lauer, S.M. Schultz, and M.E. Miller Is prophylactic cranial irradiation indicated in small-cell lung cancer? J Clin Oncol 8 2 1990 209 214
35. C.A. Kristensen, P.E. Kristjansen, and H.H. Hansen Systemic chemotherapy of brain metastases from small-cell lung cancer: a review J Clin Oncol 10 9 1992 1498 1502
36. J. Chute, T. Chen, and Feigal Twenty years of phase III trials for patients with extensive stage small-cell lung cancer: perceptible progress J Clin Oncol 17 1999 1794 1801
37. N.H. Hanna, and L.H. Einhorn Small cell lung cancer: treatment for extensive stage disease J.P. Sculier W.A. Fry Malignant tumors of the lung 2004 Springer New York 287 301
38. W. Evans, F. Shepard, R. Feld, D. Osoba, P. Dang, and G. Deboer VP-16 and cisplatin as first-line therapy for small-cell lung cancer J Clin Oncol 3 1985 1471 1477
39. B. Roth, D. Johnson, and L.H. Einhorn Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III study of the Southeastern Cancer Study Group J Clin Oncol 10 1992 282 291
40. I. Smith, S. Harland, and S. Robinson Carboplatin: a very active new cisplatin analog in treatment of small cell lung cancer Cancer Treat Rep 69 1985 43
41. D.V. Skarlos, E. Samantas, and P. Kosmidis Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group Study Ann Oncol 5 7 1994 601 607
42. G. Joos, P. Pinson, and D. Van Rentergham A randomized study comparing vincristine, adriamycin, cyclophophamide (VAC) to carboplatin, etoposide (CE) in previously untreated small cell lung cancer (SCLC) [abstract] Proc Am Soc Clin Oncol 18 1999 470a
43. E. Quoix, J. Breton, and C. Daniel Etoposide phosphate with carboplatin in treatment of elderly patients with small-cell lung cancer: a phase II study Ann Oncol 12 2001 957 962
44. A.T. Figueredo, W.M. Hryniuk, I. Strautmanis, G. Frank, and S. Rendell Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer J Clin Oncol 3 1 1985 54 64
45. D.H. Johnson, S.N. Wolff, and J.D. Hainsworth Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide J Clin Oncol 3 2 1985 170 175
46. D.H. Johnson, L.H. Einhorn, and R. Birch A randomized comparison of high-dose versus conventional-dose cyclophosphamide, doxorubicin, and vincristine for extensive-stage small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group J Clin Oncol 5 11 1987 1731 1738
47. D.C. Ihde, J.L. Mulshine, and B.S. Kramer Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer J Clin Oncol 12 10 1994 2022 2034
48. J.L. Pujol, J.Y. Douillard, and A. Riviere Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study J Clin Oncol 15 5 1997 2082 2089
49. Y. Humblet, M. Symann, and A. Bosly Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study J Clin Oncol 5 12 1987 1864 1873
50. N. Murray, R.B. Livingston, and F.A. Shepard Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group J Clin Oncol 17 8 1999 2300 2308
51. K. Furuse, M. Fukuoka, and Y. Nishiwaki Phase III study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer J Clin Oncol 16 6 1998 2126 2132
52. J.P. Sculier, M. Paesman, and G. Bureau Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party J Clin Oncol 11 10 1993 1858 1865
53. N. Thatcher, D.J. Girlin, and P. Hopwood Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council multicenter randomized trial J Clin Oncol 18 2 2000 395 404
54. T. Berghmans, M. Paesmans, and J.J. Lafitte Role of granulocyte and granulocyte-macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systemic review of the literature with methodological assessment and meta-analysis Lung Cancer 37 2 2002 115 123
55. J.H. Goldie, A.J. Coldman, and G.A. Gudauskas Rationale for the use of alternating non-cross-resistant chemotherapy Canc Treat Rep 66 1982 439 449
56. W. Evans, R. Feld, and N. Murray Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer Ann Int Med 107 1987 451 458
57. M. Fukuoka, K. Furuse, and N. Saijo Randomized trial of cyclophosphamide, doxorubicin and vincristine versus alternation of these regimens in small-cell lung cancer J Natl Cancer Inst 83 1991 855 861
58. P. Postmus, G. Scagliotti, and H. Groen Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC phase III trial Eur J Cancer 32a 1996 1498 1503
59. M. Wolf, M. Pritsch, and P. Drings Cyclic-alternating versus response-oriented chemotherapy in small cell lung cancer: a German multicenter randomized trial of 321 patients J Clin Oncol 9 4 1991 614 624
60. J.P. Sculier, T. Berghmans, and C. Castaigne Maintenance chemotherapy for small cell lung cancer: a critical review of the literature Lung Cancer 19 2 1998 141 151
61. L.H. Maurer, M. Tulloh, and R.B. Weiss A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation Cancer 45 1 1980 30 39
62. M. Cullen, D. Morgan, and W. Gregory Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomized, controlled trial Cancer Chemother Pharmacol 17 2 1986 157 160
63. N.H. Hanna, A.B. Sandler, and P.J. Loehrer Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group Randomized Study Ann Oncol 13 1 2002 95 102
64. S.G. Spiro, R.L. Souhami, and D.M. Geddes Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial Br J Cancer 59 4 1989 578 583
65. N.M. Bleehan, P.M. Fayers, and D.J. Girling Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer Br J Cancer 59 4 1989 584 590
66. M.J. Bryne, G. van Hazel, and J. Trotter Maintenance chemotherapy in limited small cell lung cancer: a randomized controlled clinical trial Br J Cancer 60 3 1989 413 418
67. D.S. Ettinger, D.M. Finkelstein, M.D. Abeloff, J.C. Ruckdeschel, S.C. Aisner, and J.C. Eggleston A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group J Clin Oncol 8 2 1990 230 240
68. B. Lebeau, C. Chastang, P. Allard, J. Migueres, F. Boita, and D. Fichet Six vs. twelve cycles for complete responders to chemotherapy in small cell lung cancer: definitive results of a randomized clinical trial Eur Respir J 5 3 1992 286 290
69. G. Giaccone, O. Dalesio, and G.J. McVie Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial J Clin Oncol 11 7 1993 1230 1240
70. N.M. Bleehan, D.J. Girling, D. Machin, and R.J. Stephens A randomized trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC): survival and prognostic factors Br J Cancer 68 1993 1150 1156
71. J.M. Beith, S.J. Clarke, R.L. Woods, D.R. Bell, and J.A. Levi Long-term follow-up of a randomized trial of combined chemoradiotherapy induction treatment, with and without maintenance chemotherapy in patients with small cell carcinoma of the lung Eur J Cancer 32A 3 1996 438 443
72. J.P. Sculier, M. Paesmans, and G. Bureau Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer J Clin Oncol 14 8 1996 2337 2344
73. J.H. Schiller, S. Adak, D. Cella, R.F. DeVore, and D.H. Johnson Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593 - a phase III trial of the Eastern Cooperative Oncology Group J Clin Oncol 19 8 2001 2114 2122
74. P.J. Loehrer, R. Ansari, and R. Gonin Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group Study J Clin Oncol 13 10 1995 2594 2599
75. J.L. Pujol, J.P. Daures, and A. Riviere Etoposide plus cisplatin with or without the combination of 4′-epidoxorubicin plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase III randomized study J Natl Cancer Inst 93 4 2001 300 308
76. D. Mavroudis, E. Papadakis, and M. Veslemes A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer Ann Oncol 12 4 2001 463 470
77. S. Mitsuoka, S. Kudoh, and Y. Takada Phase II study of cisplatin, etoposide and concurrent thoracic radiotherapy (TRT) followed by irinotecan and cisplatin in patients with limited stage small-cell lung cancer (SCLC); updated results of WJTOG 9902 Proc Am Soc Clin Oncol 23 2004 624a
78. K. Noda, Y. Nishiwaki, and M. Kawahara Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer N Engl J Med 346 2 2002 85 91
79. W.L. Akerley, J. McCoy, and P. Hesketh A phase II study of gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer (SCLC) Proc Am Soc Clin Oncol 23 2004 663a
80. G. Giaccone, C. Debruyne, and E. Felip Phase II study of BEC2/BCG vaccination in limited disease small cell lung cancer (LD-SCLC) patients following response to chemotherapy and thoracic irradiation (EORTC 08971, the SILVA study) Proc Am Soc Clin Oncol 23 2004 664a
81. J. VonPawel, J.H. Schiller, and F.A. Shepard Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer J Clin Oncol 17 2 1999 658 667
82. J. VonPawel, U. Gatzemeier, and J.L. Pujol Phase II comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer J Clin Oncol 19 6 2001 1743 1749
83. L.H. Einhorn, K. Pennington, and J. McClean Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier Oncology Group study Sem Oncol 17 Suppl. 2 1990 32 35
84. D.H. Johnson, F.A. Greco, J. Strupp, K.R. Hande, and J.D. Hainsworth Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial J Clin Oncol 8 10 1990 1613 1617
85. J.R. Eckardt, J. Von Pawel, and J.D. Hainsworth Single agent oral topotecan (po) versus intravenous (IV) topotecan in patients (pts) with chemosensitive small cell lung cancer (SCLC) [abstract] Proc Am Soc Clin Oncol 22 2003 619a
86. N. Masuda, K. Matsui, and S. Negoro Combination of irinotecan and etoposide for treatment of refractory or relapsed small-cell lung cancer J Clin Oncol 16 1998 3329 3334
87. A. Ardizzoni, G. Manegold, and R. Gaffaar Combination chemotherapy with cisplatin and topotecan as second-line treatment of sensitive and refractory small cell lung cancer (SCLC): an EORTC LCCG phase II study [abstract] Proc Am Soc Clin Oncol 18 1999 478a
88. G. Lusch, G. Rausch, and R. Kosierowski Phase II study of daily oral etoposide and hexamethymelamine (altretamine) in relapsed small cell lung cancer (SCLC) [abstract] Proc Am Soc Clin Oncol 18 1999 478a
89. D.A. Rushing, S.J. Tipping, and L.H. Close Phase I study of combination of irinotecan (CPT-11) and paclitaxel (Taxol) in previously treated patients with small cell lung cancer (SCLC) [abstract] Proc Am Soc Clin Oncol 18 1999 484a
90. S. Agelaki, A. Agelidou, and G. Blazogiannakes A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients with small cell lung cancer Eur J Cancer 35 1999 S258
91. U. Lassen, M. Sorensen, and P.B. Jensen A phase II study of a 3 day schedule with topotecan and cisplatin every three weeks in patients with previously treated small cell lung cancer and extensive disease: final results Proc Am Soc Clin Oncol 23 2004 664a
92. V. Dongiovanni, L. Buffoni, and D. Dongiovanni Second-line chemotherapy with weekly paclitaxel and gemcitabine in platinum-etoposide pretreated patients with small cell lung cancer (SCLC). A single institution phase II trial Proc Am Soc Clin Oncol 23 2004 665a
93. F.A. Shepard, G. Giaccone, and L. Seymour Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer J Clin Oncol 20 22 2002 4434 4439
94. U. Zangemeister-Wittke, T. Schenker, G.H. Luedke, and R.A. Stahel Synergistic cytotoxicity of bcl-2 antisense oligodeoxynucleotides and etoposide, doxorubicin and cisplatin on small-cell lung cancer cell lines Br J Cancer 78 8 1998 1035 1042
95. C.M. Rudin, G.A. Otterson, and A.M. Mauer A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer Ann Oncol 13 4 2002 539 545
96. M.A. Socinski, C. Weissman, and L.L. Hart Randomized phase II trial of pemetrexed with either cisplain or carboplatin in extensive stage small cell lung cancer Proc Am Soc Clin Oncol 23 2004 664a